Site Sign Off
Site Sign Off means obtaining permission from the site to conduct a research study / clinical trial at that site.
The process of site sign off takes place after Research Ethics Committee (REC) approval has been received.
Please see below the relevant SOP for the site sign off process in Beaumont Hospital
SOP, V8, 6.1.23
SOP Appendix 1 (Request for Signature Form), 6.1.23
Beaumont Hospital Research Approval Pathway, 8.1.21
Check out these Top Tips to Navigate
- Site Sign Off after REC Approval by Beaumont REC
- Site Set Up after REC Approval by an external REC
Legal Services
To request legal review of a research related contract, email the draft agreement to legalresearch@beaumont.ie
Cover for Research Studies and Clinical Trials under the Clinical Indemnity Scheme
It is a requirement for confirmation of cover under the CIS that the Principal Investigator of a research study / clinical trial taking place in Beaumont Hospital be an authorised healthcare professional employed by Beaumont Hospital. For clinical trials in conjunction with academic institutions, see also GIS State Indemnity Guidance 10 and Clinical Trial Indemnity Form (link to State Claims Agency website)
Studies / Trials involving exposure to Medical Ionising Radiation
Where a study / trial involves exposure to medical ionising radiation, and that exposure is proposed to take place in Beaumont Hospital, it is a requirement to notify the Beaumont Hospital Radiation Safety Committee / Radiation Safety Adviser.
Feedback Survey
You may be asked to complete a feedback survey at the end of the site sign off process.
